E
Emmanuel J. Favaloro
Researcher at Westmead Hospital
Publications - 731
Citations - 22370
Emmanuel J. Favaloro is an academic researcher from Westmead Hospital. The author has contributed to research in topics: Von Willebrand disease & Medicine. The author has an hindex of 60, co-authored 648 publications receiving 18261 citations. Previous affiliations of Emmanuel J. Favaloro include University of Verona & University of Sydney.
Papers
More filters
Journal ArticleDOI
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards
TL;DR: The Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards as mentioned in this paper was created in 2009 in honor of the late Eberhart F.Mammen.
Journal ArticleDOI
Results of the first survey of the EFLM Task Force Preparation of Labs for Emergencies (TF-PLE)
Giuseppe Lippi,Janne Cadamuro,Elisa Danese,Emmanuel J. Favaloro,Julien Favresse,Brandon Michael Henry,Snežana Jovičić,Tomris Ozben,Mario Plebani,Jecko Thachil +9 more
TL;DR: The European Federation of Clinical Chemistry andLaboratory Medicine (EFLM) has decided to establish a Task Force called "Preparation of Labs for Emergencies" specifically designed to improve preparedness and put into practice appropriate solutions for laboratory diagnostics in areas impacted by various anthropogenic and non-anthropogenic emergencies as mentioned in this paper .
Journal ArticleDOI
Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Platelet Morphology and Activation
Giovanni Carpenè,Gian Luca Salvagno,Matteo Gelati,Francesco Dima,Emmanuel J. Favaloro,Giuseppe Lippi +5 more
TL;DR: In this paper , the authors investigated the effects of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant spike protein variants on platelet morphology and activation.
Journal ArticleDOI
2B or not 2B? A diagnosis of von Willebrand disease a lifetime of 86 years in the making.
TL;DR: In this article, a case of 2B von Willebrand disease (2B VWD) was presented, expressing a clearly atypical VWF phenotype, but still associated with enhanced ristocetin-induced platelet aggregation, thrombocytopenia, and a previously undescribed variant (c.4130C>G; p.1377Gly).
Journal ArticleDOI
Welcome to Seminars in Thrombosis & Hemostasis 2022
TL;DR: Seminars in Thrombosis and Hemostasis (STH) as mentioned in this paper has been running for 14 years, with the current and past editors serving as the editors.